Search results
HIV breakthrough: drug trial shows injection twice a year is 100% effective against infection
The Conversation via Yahoo Canada News· 2 hours agoIt is administered just under the skin, once every six months. The randomised controlled trial, sponsored by the drug developers Gilead Sciences, tested ...
Opinion | The Pressure on Biden to Drop Out
New York Times· 5 hours agoPresident Biden told the Democratic governors that “he needs to get more sleep and work fewer hours, including curtailing events after 8 p.m.” Is that...
Ones to watch - five upcoming companies on the CAR-T scene
BioPharma-Reporter· 1 day agoCAR-T therapies took the world by storm in the last decade as a brand new type of immunotherapy for...
A new way to prevent HIV delivers dramatic results in trial
MPR News· 2 days agoFor over a decade, taking a pill like Truvada every day has been the standard of care for HIV prevention efforts. In clinical trials, this type of preventive drug, called pre-exposure prophylaxis ...
Gilead Benefit Helps Employees Navigate Cancer Care
3BL CSRwire· 3 days agoJim Candler had a successful 40-year career in system operations before coming to Gilead three years ago to bring his tech expertise to the Human...
Should You Be Concerned About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE?
Simply Wall St. via Yahoo Finance Canada· 3 days agoWe'll use ROE to examine Gilead Sciences, Inc. (NASDAQ:GILD), by way of a worked example. ROE or...
Insider Sale: Chief Medical Officer Merdad Parsey Sells Shares of Gilead Sciences Inc (GILD)
GuruFocus.com via Yahoo Finance Canada· 4 days agoFollowing this sale, the insider now owns 96,380 shares of Gilead Sciences Inc. Gilead Sciences Inc...
Should You Hold Gilead Sciences (GILD)?
Insider Monkey via Yahoo Finance Canada· 4 days agoParnassus Investments, an investment management company, released the “Parnassus Value Equity Fund” first quarter 2024 investor letter. A copy of the...
